Cerebrospinal Fluid

Cerebrospinal Fluid - most related articles:

- Potential Alzheimer's disease diagnostic test using spinal fluid - 8.1
- Stem cells take cues from CSF fluid in brain - 6.8
- Alzheimer's Disease patients may not get benefit from antioxidants - 5.4
- Biomarkers may help predict risk of Alzheimer's disease - 5
- CCSVI role in multiple sclerosis seems to be controversial - 4
- HIV virus hides in the brain - 3.9
- People with early Alzheimer's disease may have lower BMI - 3.7
- Peptide Abeta a new marker for Alzheimer's disease - 3.3
- Folic acid reduces alcohol-related damage in alcoholics - 3.2
- PET scans useful to assess Alzheimer's disease - 2.9

Cerebrospinal Fluid articles

Alzheimer's Disease patients may not get benefit from antioxidants
An antioxidant combination of vitamin E, vitamin C and a-lipoic acid (E/C/ALA) was not associated with changes in some cerebrospinal fluid biomarkers related to Alzheimer disease in a randomized controlled trial, revealed by researchers.

People with early Alzheimer's disease may have lower BMI
People in the earliest stages of Alzheimer's disease are more likely to have a lower body mass index (BMI). A new study examined 506 people with advanced brain imaging techniques and analyses of cerebrospinal fluid to look for biomarkers for Alzheimer's disease, which can be present years before the first symptoms begin.

Potential Alzheimer's disease diagnostic test using spinal fluid
Researchers at the University of Kentucky are working on a potential diagnostic test for Alzheimer's disease, based on biomarkers in cerebrospinal fluid.

Stem cells take cues from CSF fluid in brain
Proteins in fluids bathing the brain are essential for building the brain, revealed by researchers in the journal Neuron. The finding promises to advance research related to neurological disease, cancer and stem cells.

Biomarkers may help predict risk of Alzheimer's disease
Several cerebrospinal fluid (CSF) biomarkers showed good accuracy in identifying patients with mild cognitive impairment who progressed to Alzheimer's disease, revealed by US researchers in JAMA.

Peptide Abeta a new marker for Alzheimer's disease
Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.

6 Cerebrospinal Fluid articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
1.96